References
- Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287–293.
- Lee YH, Huang WC, Huang JK, Chang LS. Testesterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol. 1996;156:502–505.
- Iguchi M, Takamura C, Umekawa T, et al. Inhibitory effects of female sex hormones on urinary stone formation in rats. Kidney Int. 1999;56:479–485.
- Naghii MR, Babaei M, Hedayati M. Androgens involvement in the pathogenesis of renal stones formation. PLoS One 2014;9:e93790.
- Otunctemur A, Ozbek E, Cakir SS, et al. Urolithiasis is associated with low serum testosterone levels in men. Arch Ital Urol Androl. 2015;87:83–86.
- Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149:15–24.
- Araujo AB, Wittert GA. Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab. 2011;25:303–319.
- Chariyavilaskul P, Poungpairoj P, Chaisawadi S, et al. In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers. Urolithiasis 2015;43:125–134.